Trial Profile
Registry for Estimation of Warfarin and Rivaroxaban in Atrial Fibrillation Patients With Coronary Stent Implantation (REWRAPS)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Apr 2018
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Warfarin
- Indications Embolism and thrombosis; Stroke
- Focus Adverse reactions; Therapeutic Use
- Acronyms REWRAPS
- 17 Apr 2018 Status changed from recruiting to completed.
- 26 Mar 2015 New trial record